WAYNE, Pa. (AP) — WAYNE, Pa. (AP) — Aclaris Therapeutics Inc. (ACRS) on Thursday reported a loss of $15.1 million in its first quarter.
On a per-share basis, the Wayne, Pennsylvania-based company said it had a loss of 12 cents.
The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 17 cents per share.
The specialty pharmaceutical company posted revenue of $1.5 million in the period, missing Street forecasts. Four analysts surveyed by Zacks expected $4.2 million.
The company’s shares closed at $1.25. A year ago, they were trading at $1.34.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ACRS at https://www.zacks.com/ap/ACRS
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
